Supplemental Schedule of Non-Cash Investing and Financing Activities (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Stock Issued		$ 400	$ 600
Capital Expenditures Incurred but Not yet Paid		300	500
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability		300	0
Joint Venture Agreement With BRE2 LLC [Member]
Accrued Investment Income Receivable		$ 200	$ 0
Joint Venture Agreement With BRE2 LLC [Member] | Forecast [Member]
Accrued Investment Income Receivable	$ 1,100
Return Of Equity	600
Net Profit	$ 500